SUMMARY. Twice weekly plasma and urine measurements were made in 24 very low birth weight infants. Intravenous feeding was given whilst infants required respiratory support. Subsequently they received breast milk or formula milk with a vitamin D supplement of 400U/day. Fourteen babies required intravenous feeding for more than 10 days. Six developed radiological rickets or severe osteoporosis, and these infants had plasma phosphate levels < 1. 2 mmollL on breast milk or < 1. 8 mmollL on formula milk. Babies without radiological rickets had plasma phosphate levels > 1. 2 mmollL on breast milk and > 1. 8 mmollL in all but one on formula milk. Successful treatment of rickets was associated with a rise in plasma phosphate to the above levels. Untimed urine calcium and phosphate concentrations expressed as creatinine ratios were not helpful in detecting babies with rickets, but may be useful in monitoring therapy.
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Metabolic bone disease, caused by phosphate, calcium or vitamin D deficiency is well recognized in very low birthweight (VLBW) infants. 1 Most infants develop osteopenia due to a reduction in concentration of bone mineral whilst a minority develop frank rickets. Almost all rickets in preterm infants occurs in those < 1500 g birthweight, most being < 1000g where the prevalence in survivors may be 50070. 2 The diagnosis has been made as early as 5 weeks after birth and most cases are detected by 15 weeks. Osteopenia and rickets may be asymptomatic but can produce pathological fractures and may contribute to respiratory problems.t-"
The degree of osteopenia is best measured by photon absorptiometry-" and is difficult to assess radiologically, 5 whereas the diagnosis of rickets is confirmed by radiology." Plasma alkaline phosphatase has been advocated as a useful biochemical screening test for ricketss-? but the levels in babies are very variable 10 -12 infants by measuring serial plasma and urine calcium and phosphate levels until discharge. The findings related to intravenous feeding have been published," and we now report the findings on milk feeds.
PATIENTS AND METHODS

Patients
Twenty-four VLBW infants admitted to the Trevor Mann Baby Unit in Brighton were studied over a 6 month period. All were Caucasian and none had congenital abnormalities. Six had birthweights below 80070 of the mean for their gestational age." Twenty required intermittent positive pressure ventilation, 17 for hyaline membrane disease and three for extreme prematurity.
Methods
Nutrition. From day 3, infants requiring respiratory support were given only intravenous (IV) fluids using one of two regimens, identical except for their calcium and phosphate content.!" Fourteen babies were given IV feeding for more than 10 days; five received regimen A which provided mean calcium and phosphate intakes of 0'55 and 0'44mmoIlkg/day and nine received regimen B which provided intakes of 1· 08 and O' 89 mmoIlkg/day, respectively. The vitamin D intake on both regimens was about 100UIkglday. When the baby was stable and free from respiratory distress, two hourly nasogastric feeds were started using expressed breast milk increasing until at least 1SO mL/kglday was tolerated. If the mother did not then intend to breast feed, a standard formula milk was given instead. Infants were not given breast and formula milk simultaneously. The formula milks used had energy content 650 kcal/L, vitamin D 420-440 U/L, calcium 10-12 mmol/L and phosphate 9-11 mmoIlL (data from manufacturer). A vitamin D supplement of 400 U/day was given as soon as milk feeds were started. As the babies matured, the frequency of feeding was reduced and oral feeding commenced. Theophylline was given to 10 babies but no infant received indomethacin or frusemide while on milk feeds. Alfacalcidol (Io-hydrcxychclecalciferol) was given when necessary at a dose of 0·1 J.lg/kg/day.
Measurements. Venous or arterial samples for plasma calcium, phosphate and creatinine were obtained at twice weekly intervals from all patients until their discharge home. Manual ultramicro procedures were used for all plasma assays and urine calcium and phosphate were measured on an American Monitor Parallel analyser (American Monitor, Burgess Hill, UK).
Radiographs of the left wrist were taken at fortnightly intervals until discharge in infants given IV feeding for more than 10 days, but not in the other babies. Rickets was diagnosed on finding an irregular frayed metaphysis with widening and cupping. Fluid intake was recorded and body weight was measured at regular intervals.
Data analysis. Urine calcium and phosphate
excretion was related to creatinine, as discussed previously." Only the results obtained after the age of 10 days, when growth could be expected, are considered here. Most of the variation in results occurred between the feeding regimens, rather than with postnatal age; therefore the results were analysed according to the type of feed given. The change over from breast to formula feeding was completed within 5 days, measurements in the first 5 days of formula feeding were excluded, as were those on breast milk given for less than 10 days. The mean postnatal age, weight, milk intake and growth rate of each baby during the period of breast or formula feeding were Ann Clin Biochem 1993: 30 calculated and used to derive overall mean values for each group. Means and standard deviations for each group are shown.
RESULTS
The infants were divided into two groups, according to the duration of IV feeding ( Table  1 ). The 14 babies given IV feeding for more than 10 days had lower birthweights, lower gestational ages, required more respiratory support and had longer stays in hospital than the 10 given IV feeding for less than 10 days. Radiological rickets developed in four of the 14 infants on long-term IV feeding. A further two of these developed generalized osteopenia with possible rickets. The results of these six are considered separately. The results of the remaining babies on breast or formula feeding are summarized in Table 2 . Babies given IV feeding for more than 10 days subsequently had lower milk intakes and growth rates, but because of their greater postnatal age their weights when commencing breast or formula feeding were comparable.
Breast milk
The results on breast milk were similar in the two groups, except for the lower plasma calcium in babies given IV feeding for more than 10 days. This may reflect lower plasma protein levels. Plasma phosphate varied widely (1'2-2'2 mmoIlL), with only one measurement below 1· 2 mmoIlL in a baby given regimen A for 6 days. Urine phosphate was less than 0'5 mmollmmol creatinine in 75010 of the samples. Urine calcium was higher but variable up to 7 mmollmmol creatinine.
Formula milk
The results on formula milk differed considerably from those on breast milk. Plasma phosphate was greater than 2· 0 mmoIlL in all babies given IV feeding for less than 10 days and greater than 1. 8 mmoIlL in all except one given IV feeding for more than 10 days. In all samples urine phosphate (2-12 mmol/mmol creatinine) exceeded urine calcium (0' 1-1 . 5 mmol/mmol creatinine).
Infants with definite or possible radiological rickets
Four infants developed radiological rickets, two on regimen A and two on regimen B. Two others on regimen A showed generalized osteopenia with possible rickets. All had received IV feeding for more than 10 days following which either breast milk or formula milk was used. The mean plasma phosphate and alkaline phosphatase concentrations during the different types of feeding for each infant are shown in Table 3 . Urinary excretion of calcium and phosphate in the infants without rickets were not significantly different from those shown in Table 2 for infants without rickets. Table 3 also shows the feeding regimen at the time of diagnosis and the treatment/outcome for each infant. One infant (JC) who developed rickets was a twin, her brother (MC) showing no signs of rickets. Infant JC was given regimen A, her brother was given regimen B. Whilst on IV feeding JC had lower plasma phosphate concentrations ( Fig. 1 ) a difference which persisted on breast milk (JC:l'03 mmollL, MC:l'56 mmollL). There were no differences in alkaline phosphatase activities between the twins at any time. Both infants were then given formula milk which produced very similar biochemical results (mean plasma phosphate of 1·98 mmollL in JC and 1·96 mmollL in her brother). No specific treatment was given to JC and her rickets resolved spontaneously. --=Phosphate; ---=calcium.
DISCUSSION
Detection of rickets
In clinical practice, the diagnosis of rickets is established radiologically,' but because frequent X-rays are undesirable, biochemical tests are important in screening and are useful in monitoring therapy and in assessing feeding regimens.
Calcium and phosphorus metabolism in the neonate, along with associated biochemical tests, has been recently reviewed;" The results in the literature of biochemical tests in VLBW infants with reported rickets are summarized in Table 4 , which shows the results in formula and breast milk fed infants at the time of diagnosis separately.
Plasma phosphate. Exclusively breast milk fed low birthweight infants, in whom rickets had been excluded radiologically, have been shown to have mean plasma phosphate values between 1.29 and 1. 78 mmol/L. 35-3, In this study the breast milk fed infants without rickets had plasma phosphate concentrations consistently above 1· 2 mmol/L. All four breast milk fed babies with radiological abnormalities had plasma phosphate values below 1. 2 mmol/L. These results, together with the cases reported previously, suggest that in breast milk fed infants rickets is unlikely if the plasma phosphate is greater than 1.2 mrnol/L, but should be excluded radiologically at levels repeatedly below this. Low birthweight infants, without radiological rickets, fed standard or low birthweight formula milks, have mean plasma phosphate concentrations consistently above I' 9 mmol/L and usually above 2' 2 mmol/L. 35, 36, [38] [39] [40] In this study six of seven formula milk fed infants who did not develop rickets had plasma phosphate concentrations above 1· 8 mmol/L. Of three formula fed infants with a plasma phosphate below I· 8 mmol/L, two had definite rickets. Rickets is likely in formula fed infants if the plasma phosphate is repeatedly below l' 8 mmol/L, but may still occur at values above this.
The low phosphate concentrations in formula milk fed infants with rickets are associated with high urine phosphate excretion and are likely to be due to secondary hyperparathyroidism and not phosphate deficiency. The previous studies shown in Table 4 all showed high PTH concentrations in formula fed infants with rickets. There is some doubt, however, about the results from earlier studies as C-or N-terminal PTH assays were used 17,20,21,22,23 17, 18, 19 12, 17, 18, 19,20,21,22, 23,24 17 2,17, 18,20,21,22,23,24 18, 22, 23 18, 19, 20, 22 24 Formula milk 4, 25, 27, 28, 29, 30, 31, 32,34 17,25,26,29,31,32 27 25, 29, 32, 34 4,17,25,26,27,28,30,31, 32, 33 4,31 29, 31, 32, 33 4, 28, 31, 34 3D, 31 28, 30, 31, 32, 34 25-0HD = 25 hydroxyvitamin D; 1,25-(OH)2 D = 1,25 dihydroxyvitamin D; iPTH = immunoreactive parathyroid hormone.
which are now known to measure inactive fragments of PTH.
Plasma alkaline phosphatase activity. High plasma alkaline phosphatase (ALP) activities have been advocated as a screening test for rickets of prernaturityt-? but are not found in all cases. [10] [11] [12] In our study one infant with rickets had a peak ALP activity within the range found in babies without rickets, and in another ALP fell to normal during active rickets. The other babies with rickets had clearly elevated ALP activities.
Urine calcium and phosphate. Balance studies" suggest that, in breast milk fed babies, urine calcium should be 1-7 mmol/mmol creatinine with urine phosphate of 3-14 mmol/mmol creatinine. In this study, most breast and formula milk fed babies without rickets had values for urine calcium and phosphate within these ranges. Infants with rickets might be expected to have higher urine calcium results if breast milk fed and higher urine phosphate excretion if formula fed. However, no such differences were found in this study.
Plasma vitamin D metabolites. Although the measurement of plasma 25-hydroxyvitamin D is necessary to diagnose vitamin D deficiency, it is of little value as a screening test for rickets of prematurity because (as shown in Table 4 ) normal concentrations are the rule in breast milk fed cases and are common in formula milk fed cases.
CONCLUSIONS: IMPLICATIONS FOR TREATMENT
Breast milk feeding is associated with phosphate deficiency rickets, characterized by normal to high plasma calcium and plasma phosphate below 1. 2 mmoIlL. In contrast, formula milk feeding is associated with calcium and/or vitamin D deficiency rickets, characterized by normal to low plasma calcium and plasma phosphate below 1·9mmoIlL.
The aim of treatment in preterm infants is to improve calcium and phosphate retention. In breast milk fed babies, this is achieved by correcting phosphate deficiency, either by changing to formula milk or alternatively by phosphate supplementation.P-" Supplementation will only increase calcium retention up to 0·9 mmol/kg/day," which may not be sufficient to correct rickets and net retention will still be suboptimal for long-term bone mineralization. In utero calcium retention at 29-32 weeks is estimated to be about 2· 5 mmoIlkg/day. 43 It should be possible to predict the extent to which phosphate supplementation will improve calcium retention from the plasma and urine calcium levels before treatment. If plasma and urine calcium are high, then a good response is likely. If plasma and urine calcium are low, then little improvement in calcium retention is likely with phosphate supplements.
Plasma phosphate measurements should also be useful in monitoring the response to treatment, concentrations increasing to above I . 8 mmol/L indicating a good response. Phosphate supplementation produces a transient fall in plasma calcium which recovered without calcium supplements in three of four infants in our study presumably due to induction of PTH secretion. If phosphate supplementation is insufficient to correct rickets, then calcium supplements can be added. In formula milk fed babies, increased calcium retention is produced by vitamin D44 or calcium supplementation,36,38,45 the latter producing retention rates of up to 2·0 mmol/kg/day without the addition of extra phosphate. Reported cases of rickets in formula fed infants have responded to treatment with vitamin D in doses up to 5000 U/d ay4,17,25-27,29,32,46 1,25 di-hydroxyvitamin D 30 or its analogue alfacalcidoI. 28 The finding of high 1,25 di-hydroxyvitarnin D levels in cases of rickets makes the response to treatment with alfacalcidol seem paradoxical. In general, the sequence of events associated with successful treatment is initial correction of hypocalcaemia, followed by an increase in plasma phosphate and finally radiological healing. In practice, if the plasma phosphate fails to rise above I .8 mmol/L over a few weeks with vitamin D alone, calcium supplementation may be necessary.
Rickets of prematurity can largely be prevented by early IV feeding with a regimen providing calcium and phosphate intakes up to I' 2 and 1'6 mmol/kg/day respectively, by phosphate and calcium supplementation of breast milk 12 and by calcium supplementation of formula milk with vitamin D intakes of 460 U/day,47 This is based on the observed improvement in biochemical indices and longer term follow-up studies are needed to prove that these regimens supply adequate mineral substrate for long-term bone mineralization.
